Skip to main content

Insight Molecular Diagnostics Inc.

IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001642380

No open-market purchases or sales by Insight Molecular Diagnostics Inc. insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q3 2026, worth $66.6M in total; no superinvestor holds it.

13F holders, Q3 2026

Institutional positions in Insight Molecular Diagnostics Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
43
+5 vs. Q2 2026
Shares held
18.5M
+567.1K (+3.2%) vs. Q2 2026
Total value
$66.6M
−$39.5M (−37.2%) vs. Q2 2026
New holders
13
12 more added
Sold out
8
7 more reduced

2 institutions that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IMDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2026: 43 institutions
Q1 2021: 87 institutionsQ2 2021: 91 institutionsQ3 2021: 95 institutionsQ4 2021: 89 institutionsQ1 2022: 86 institutionsQ2 2022: 76 institutionsQ3 2022: 65 institutionsQ4 2022: 59 institutionsQ1 2023: 52 institutionsQ2 2023: 47 institutionsQ3 2023: 30 institutionsQ4 2023: 26 institutionsQ1 2024: 25 institutionsQ2 2024: 23 institutionsQ3 2024: 21 institutionsQ4 2024: 27 institutionsQ1 2025: 30 institutionsQ2 2025: 30 institutionsQ3 2025: 27 institutionsQ4 2025: 35 institutionsQ1 2026: 41 institutionsQ2 2026: 40 institutionsQ3 2026: 43 institutions
Value heldQ3 2026: $66.6M
Q1 2021: $283.0MQ2 2021: $324.6MQ3 2021: $201.9MQ4 2021: $120.1MQ1 2022: $81.1MQ2 2022: $61.8MQ3 2022: $48.3MQ4 2022: $19.5MQ1 2023: $19.7MQ2 2023: $21.1MQ3 2023: $14.3MQ4 2023: $11.1MQ1 2024: $12.8MQ2 2024: $21.1MQ3 2024: $20.4MQ4 2024: $20.0MQ1 2025: $49.2MQ2 2025: $48.9MQ3 2025: $54.1MQ4 2025: $124.9MQ1 2026: $62.1MQ2 2026: $108.9MQ3 2026: $66.6M
Institutions holding IMDX and their total value by quarter
QuarterHoldersValue
Q3 202643$66.6M
Q2 202640$108.9M
Q1 202641$62.1M
Q4 202535$124.9M
Q3 202527$54.1M
Q2 202530$48.9M
Q1 202530$49.2M
Q4 202427$20.0M
Q3 202421$20.4M
Q2 202423$21.1M
Q1 202425$12.8M
Q4 202326$11.1M
Q3 202330$14.3M
Q2 202347$21.1M
Q1 202352$19.7M
Q4 202259$19.5M
Q3 202265$48.3M
Q2 202276$61.8M
Q1 202286$81.1M
Q4 202189$120.1M
Q3 202195$201.9M
Q2 202191$324.6M
Q1 202187$283.0M

Institutions, Q3 2026

Shares, value and share of portfolio for each institution holding Insight Molecular Diagnostics Inc.; share changes are against Q2 2026.

Institutions holding IMDX in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Broadwood Capital Inc12,684,884$45.5M2.92%00.0%Unchanged
AWM Investment Company, Inc.2,771,765$9.95M0.96%−64,927−2.3%Reduced
Vanguard Capital Management LLC731,391$2.63M0.00%−4,456−0.6%Reduced
Family Office Research LLC650,234$2.33M0.90%+281,385+76.3%Added
Geode Capital Management, LLC270,558$972.1K0.00%+13,655+5.3%Added
FNY Investment Advisers, LLC242,264$869.0K0.22%+59,703+32.7%Added
Two Sigma Investments, LP201,914$724.9K0.00%+190,813+1,718.9%Added
Vanguard Fiduciary Trust Co150,918$541.8K0.00%+26,342+21.1%Added
BlackRock, Inc.148,526$533.2K0.00%−1,995−1.3%Reduced
State Street Corp121,624$436.6K0.00%+29,500+32.0%Added
Walleye Capital LLC57,587$206.7K0.00%+57,587New
Northern Trust Corp53,288$191.3K0.00%+4,198+8.6%Added
UBS Group AG44,872$161.1K0.00%−8,404−15.8%Reduced
Susquehanna International Group, LLP44,042$158.1K0.00%+44,042New
Advisor Group Holdings, Inc.39,136$140.5K0.00%00.0%Unchanged
Bank of America Corp37,214$133.6K0.00%+37,214New
Jane Street Group, LLC36,081$129.5K0.00%−121,601−77.1%Reduced
Jump Financial, LLC35,400$127.1K0.00%+35,400New
Citadel Advisors LLC33,511$120.3K0.00%+33,511New
Marshall Wace, LLP22,830$82.0K0.00%+6,233+37.6%Added
Zevenbergen Capital Investments LLC22,000$79.0K0.00%+22,000New
Gsa Capital Partners LLP19,247$69.0K0.00%+19,247New
Jefferies Financial Group Inc.18,100$65.0K0.00%00.0%Unchanged
Morgan Stanley17,544$63.0K0.00%−17,971−50.6%Reduced
Savvy Advisors, Inc.15,000$53.9K0.00%+15,000New
Flatrock Wealth Partners LLC14,300$51.3K0.02%+1,256+9.6%Added
Vanguard Global Advisers, LLC12,918$46.4K0.00%+7,143+123.7%Added
Cerity Partners LLC11,947$42.9K0.00%+11,947New
Private Advisor Group, LLC10,416$37.4K0.00%00.0%Unchanged
Smith, Moore & Co.10,000$35.9K0.00%+10,000New
BNP Paribas Arbitrage, SA9,540$34.2K0.00%+3,739+64.5%Added
EverSource Wealth Advisors, LLC5,000$17.9K0.00%00.0%Unchanged
Transce3nd, LLC1,000$3.02K0.00%+1,000New
Barclays PLC584$2.10K0.00%+584New
JPMorgan Chase & Co309$1.04K0.00%+155+100.6%Added
SBI Securities Co., Ltd.185$6640.00%00.0%Unchanged
Golden State Equity Partners100$3590.00%+100New
Jones Financial Companies LLLP63$2470.00%00.0%Unchanged
Caitong International Asset Management Co., Ltd39$1400.00%−6−13.3%Reduced
Piscataqua Savings Bank25$890.00%00.0%Unchanged
Albion Financial Group7$260.00%00.0%Unchanged
Wells Fargo & Company7$250.00%00.0%Unchanged
Farther Finance Advisors, LLC1$40.00%00.0%Unchanged
Millennium Management LLC0$00.00%−82,499−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−14,029−100.0%Sold out
Axq Capital, LP0$00.00%−13,407−100.0%Sold out
XTX Topco Ltd0$00.00%−10,743−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−2,691−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−1,960−100.0%Sold out
Cassaday & Co Wealth Management LLC0$00.00%−6−100.0%Sold out
Global Retirement Partners, LLC0$00.00%−1−100.0%Sold out
Pura Vida Investments, LLC––––Not filed
Royal Bank of Canada––––Not filed